NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/12/2024
Back to search
Official data from USPTO
TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
06/12/2024
Trademark type
Combined
Nice classes
35, 44
Filing date
11/04/2016
Registration date
12/04/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/12/2024
Last transaction
06/12/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2018-04-00
First use in commerce
2018-04-00
Drawing code
3
Owner type
03
Owner location
Foster City, CA
Examiner
MACIOL II,EUGENE VALENTINE-JO
Current location
FILE DESTROYED
Mark description
The mark consists of a diamond shape divided in two by a horizontally aligned wavy band with the top portion in the color blue and the bottom portion in the color orange, to the right of this design is the wording "TRUVADA" displayed in large letters on a single line in the color gray, the wording "EMTRICITABINE 200 MG / TENOFOVIR" appears below this on a single line in the color gray, "DISOPROXIL FUMARATE 300 MG TABLETS" appears below this on a single line in the color gray and "FOR PREP PRE-EXPOSURE PROPHYLAXIS" appears below this on a single line in the color gray with the wording "FOR PRE-EXPOSURE PROPHYLAXIS" in the color blue and the wording "PREP" in the color white inside a blue oval.
Holders and representatives
Holders
Gilead Sciences, Inc.
Representatives
Jack Wessel Gilead Sciences, Inc.
Technical classification
Nice Classes
Class 35Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting public awareness on the prevention of HIV infection
Class 44
Medical servicesproviding information regarding the prevention of HIV infection
Publications
History of USPTO decisions and trademark events.
55 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/12/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/12/2024
E815
TEAS SECTION 8 & 15 RECEIVED
12/07/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/04/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/07/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/04/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/01/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/31/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/13/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/13/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/09/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/08/2018
GNRT
NON-FINAL ACTION E-MAILED
05/08/2018
CNRT
SU - NON-FINAL ACTION - WRITTEN
05/08/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/11/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/09/2018
IUAF
USE AMENDMENT FILED
03/22/2018
EISU
TEAS STATEMENT OF USE RECEIVED
03/22/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/28/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/03/2017
PUBO
PUBLISHED FOR OPPOSITION
10/03/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/13/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/28/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
08/10/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/10/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
08/10/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/10/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
08/07/2017
PBSR
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
08/07/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
07/18/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/30/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/23/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
06/23/2017
ALIE
ASSIGNED TO LIE
06/22/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/22/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
06/22/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/22/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/22/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
06/20/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/31/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/16/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/15/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/15/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/18/2017
GNRT
NON-FINAL ACTION E-MAILED
01/18/2017
CNRT
NON-FINAL ACTION WRITTEN
01/18/2017
DOCK
ASSIGNED TO EXAMINER
01/14/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/10/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2016
NWAP
NEW APPLICATION ENTERED
11/08/2016
Continuous trademark protection
Get notified about every new filing that threatens TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.